CJASN
@CJASN
The leading voice for the latest advancements in clinical nephrology. Official publication of @ASNKidney. Impact Factor 9.8.
27-08-2014 16:02:37
3,6K Tweets
27,7K Followers
1,1K Following
SGLT2 inhibitors reduce the risk of cardiovascular disease in patients with CKD. This study found SGLT2 inhibitors reduced risk of cardiovascular death, having the most pronounced effects on risk of deaths attributed to heart failure bit.ly/CJASN0470
David C Wheeler